Pax-5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcome

Denzinger, Stefan and Burger, Maximilian and Hammerschmied, Christine G. and Wieland, Wolf F. and Hartmann, Arndt and Obermann, Ellen C. and Stoehr, Robert (2008) Pax-5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcome. PATHOLOGY, 40 (5). pp. 465-469. ISSN 0031-3025,

Full text not available from this repository. (Request a copy)

Abstract

Aims: Pax (paired box) genes comprise a gene family crucial for cell differentiation that encodes a set of transcription factors. Recently, Pax-5 mRNA expression was suggested as a prognostic marker in bladder cancer (BC). However, a functional role of Pax-5 in BC is questionable because the protein expression was not determined in these studies. Therefore, we evaluated Pax-5 protein expression in an unselected, consecutive series of BC. Methods: We immunohistochemically investigated Pax-5 protein expression in 100 archival bladder tumours and 22 normal urothelial samples using tissue microarray (TMA) technology and a monoclonal antibody against Pax-5. Staining intensity and percentage of positively stained cells were determined and correlated to histopathological characteristics of the tumours and clinical follow-up data. Results: All 22 samples of histopathologically normal urothelium were negative for Pax-5 protein expression. Overall, 70 of 100 tumours gave interpretable results. Only seven of 70 (10%) cases showed a positive nuclear Pax-5 staining but without significant correlation to clinicopathological characteristics. Interestingly, we could observe Pax-5 positive lymphocytes located within the tumour or closely adjacent in the underlying stroma in 24 of 70 (34%) cases in our series. Conclusions: Pax-5 protein expression is infrequent in BC. Absence of correlation to clinicopathological characteristics suggests a minor functional role of Pax-5 in BC. Pax-5 positive lymphocytes within reactive infiltrates adjacent to the tumour warrant further studies evaluating biological, immunological and clinical relevance.

Item Type: Article
Uncontrolled Keywords: TRANSITIONAL-CELL CARCINOMA; BREAST-CANCER; GENES; PROGRESSION; TUMORS; INFLAMMATION; ASSOCIATION; PROGNOSIS; SURVIVAL; LEUKEMIA; bladder cancer; tissue microarray; Pax-5; immunohistochemistry
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Urologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 23 Nov 2020 07:52
Last Modified: 23 Nov 2020 07:52
URI: https://pred.uni-regensburg.de/id/eprint/31744

Actions (login required)

View Item View Item